Global Tardive Dyskinesia Treatment Market Report 2025

Item added to cart!

Published : December 2025

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF

Purchase This Report

Tardive Dyskinesia Treatment Global Market Report 2025

Name: Tardive Dyskinesia Treatment Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Treatment Type (Medications, Botulinum Toxin Injections, Deep Brain Stimulation, Other Treatment Types), By Drug (Valbenazine, Amantadine, Tetrabenazine, Clonazepam, Other Drugs), By Route Of Administration (Oral Administration, Injection, Transdermal Patches), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels), By End-Users (Hospitals, Specialty Clinics, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tardive Dyskinesia Treatment Market Overview

• Tardive Dyskinesia Treatment market size has reached to $2.40 billion in 2024

• Expected to grow to $3.61 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%

• Growth Driver: The Rise In Psychiatric Disorders Driving The Growth Of The Market Due To Increasing Mental Health Burden

• Market Trend: Innovative Drug Formulations Aim To Improve Care For Patients With Swallowing Difficulties

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Tardive Dyskinesia Treatment Market?

Tardive dyskinesia treatment refers to the medical management and therapeutic interventions aimed at reducing or controlling the involuntary, repetitive movements caused by long-term use of dopamine receptor-blocking agents, especially antipsychotics.

The main treatment types of tardive dyskinesia are medications, botulinum toxin injections, deep brain stimulation, and other treatment types. Medications refer to drugs specifically used to manage and reduce the involuntary, repetitive movements caused by long-term use of antipsychotic medications. Commonly used drugs are valbenazine, amantadine, tetrabenazine, clonazepam, and others. These treatments are administered through various routes, including oral administration, injection, and transdermal patches. These various distribution channels are hospital pharmacies, retail pharmacies, and others, and cater to various end users, including hospitals, specialty clinics, and others.

Tardive Dyskinesia Treatment Market Size and growth rate 2025 to 2029: Graph

What Is The Tardive Dyskinesia Treatment Market Size 2025 And Growth Rate?

What Is The Tardive Dyskinesia Treatment Market Growth Forecast?

The tardive dyskinesia treatment market size is expected to see strong growth in the next few years. It will grow to $3.61 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to growing demand for safer antipsychotic therapies, rising awareness through advocacy and education campaigns, growing focus on personalized mental health treatments, rising healthcare spending on neurological and psychiatric disorders, and a growing number of psychiatric patients under long-term therapy. Major trends in the forecast period include developing neuroprotective strategies, developing dual-action therapies, integration of real-world evidence (RWE) in drug evaluation, integration of digital biomarkers, and innovation in non-dopaminergic therapeutics.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Tardive Dyskinesia Treatment Market Segmented?

1) By Treatment Type: Medications, Botulinum Toxin Injections, Deep Brain Stimulation, Other Treatment Types

2) By Drug: Valbenazine, Amantadine, Tetrabenazine, Clonazepam, Other Drugs

3) By Route Of Administration: Oral Administration, Injection, Transdermal Patches

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels

5) By End-Users: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Medications: Antipsychotic Medications, Benzodiazepines, Dopamine-Depleting Agents, Anticholinergic Agents

2) By Botulinum Toxin Injections: Facial Muscle Injections, Neck Muscle Injections, Limb Muscle Injections, Customized Injection Protocols

3) By Deep Brain Stimulation: Subthalamic Nucleus Stimulation, Globus Pallidus Interna Stimulation, Thalamic Stimulation, Multi-Target Stimulation

4) By Other Treatment Types: Supportive Therapies, cognitive behavioral therapy, Physical Rehabilitation, Emerging Experimental Treatments

What Is Driving The Tardive Dyskinesia Treatment Market? The Rise In Psychiatric Disorders Driving The Growth Of The Market Due To Increasing Mental Health Burden

The increasing prevalence of psychiatric disorders is expected to propel the growth of the tardive dyskinesia treatment market going forward. Psychiatric disorders refer to a wide range of mental health conditions that affect a person's mood, thinking, behavior, and overall functioning, often requiring clinical diagnosis and treatment. The prevalence of psychiatric disorders is growing due to rising stress and lifestyle pressures resulting from high workloads, social isolation, and limited time for self-care. Tardive dyskinesia treatment helps manage involuntary movement symptoms, improving overall treatment outcomes and quality of life for individuals with psychiatric disorders who require long-term antipsychotic medication. For instance, in March 2024, according to the House of Commons Library, a UK-based research and information service, in 2022, the proportion of 17- to 19-year-olds with a probable mental disorder increased from 17% in 2021 to 26%. Therefore, the increasing prevalence of psychiatric disorders is driving the growth of the tardive dyskinesia treatment industry.

Who Are The Major Players In The Global Tardive Dyskinesia Treatment Market?

Major companies operating in the tardive dyskinesia treatment market are AbbVie Inc., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Jazz Pharmaceuticals plc, Kyowa Kirin Co Ltd., H. Lundbeck A/S, Zydus Lifesciences Limited, Neurocrine Biosciences Inc., Luye Pharma Group Ltd., Acadia Pharmaceuticals Inc., Upsher-Smith Laboratories LLC, SteriMax Inc., Adamas Pharmaceuticals Inc., ChemWerth Inc, Sunovion Pharmaceuticals Inc., Mitsubishi Tanabe Pharma Corporation, Synnat Pharma Pvt. Ltd, LGM Pharma LLC, and SOM Biotech S.A.

What Are The Key Trends Of The Global Tardive Dyskinesia Treatment Market? Innovative Drug Formulations Aim To Improve Care For Patients With Swallowing Difficulties

Major companies operating in the tardive dyskinesia treatment market are focusing on developing innovative drugs, such as sprinkle capsule formulations, to improve medication adherence for patients with swallowing difficulties. Sprinkle capsule formulations are medications designed to be opened and sprinkled onto soft food, making them easier to swallow for patients with dysphagia or difficulty taking whole capsules. For instance, in July 2024, Neurocrine Biosciences Inc., a US-based biotechnology company, launched Ingrezza sprinkle (valbenazine) capsules, the leading prescribed vesicular monoamine transporter 2 (VMAT2) inhibitor for treating adults with tardive dyskinesia and chorea associated with Huntington's disease. This VMAT2 inhibitor works by regulating dopamine levels in the brain to help manage involuntary movements. The medication is available as a once-daily oral capsule, including a sprinkle formulation designed to ease administration for patients who have difficulty swallowing.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Tardive Dyskinesia Treatment Market? Johnson & Johnson Acquires Intra-Cellular Therapies To Expand Mental Health And Neuroscience Portfolio

In April 2025, Johnson & Johnson, a US-based pharmaceutical industry company, acquired Intra-Cellular Therapies for an undisclosed amount. With this acquisition, Johnson & Johnson aims to strengthen its leadership in neuroscience and expand its presence in the fast-growing mental health treatment market. Intra-Cellular Therapies Inc. is a US-based pharmaceutical company that specializes in providing treatments for tardive dyskinesia.

What Is The Regional Outlook For The Global Tardive Dyskinesia Treatment Market?

North America was the largest region in the tardive dyskinesia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Tardive Dyskinesia Treatment Market?

The tardive dyskinesia treatment market includes revenues earned by entities through botulinum toxin injection services, deep brain stimulation procedures, and diagnostic and monitoring services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Tardive Dyskinesia Treatment Industry?

The tardive dyskinesia treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the tardive dyskinesia treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Tardive Dyskinesia Treatment Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$2.61 billion
Revenue Forecast In 2034	$3.61 billion
Growth Rate	CAGR of 8.4% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	Treatment Type, Drug, Route Of Administration, Distribution Channel, End-Users
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	AbbVie Inc., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Jazz Pharmaceuticals plc, Kyowa Kirin Co Ltd., H. Lundbeck A/S, Zydus Lifesciences Limited, Neurocrine Biosciences Inc., Luye Pharma Group Ltd., Acadia Pharmaceuticals Inc., Upsher-Smith Laboratories LLC, SteriMax Inc., Adamas Pharmaceuticals Inc., ChemWerth Inc, Sunovion Pharmaceuticals Inc., Mitsubishi Tanabe Pharma Corporation, Synnat Pharma Pvt. Ltd, LGM Pharma LLC, and SOM Biotech S.A.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Tardive Dyskinesia Treatment Market Characteristics

3. Tardive Dyskinesia Treatment Market Trends And Strategies

4. Tardive Dyskinesia Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Tardive Dyskinesia Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Tardive Dyskinesia Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Tardive Dyskinesia Treatment Market Growth Rate Analysis

5.4. Global Tardive Dyskinesia Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Tardive Dyskinesia Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Tardive Dyskinesia Treatment Total Addressable Market (TAM)

6. Tardive Dyskinesia Treatment Market Segmentation

6.1. Global Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Medications

Botulinum Toxin Injections

Deep Brain Stimulation

Other Treatment Types

6.2. Global Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Valbenazine

Amantadine

Tetrabenazine

Clonazepam

Other Drugs

6.3. Global Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Administration

Injection

Transdermal Patches

6.4. Global Tardive Dyskinesia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Pharmacies

Retail Pharmacies

Other Distribution Channels

6.5. Global Tardive Dyskinesia Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Homecare

Specialty Clinics

Other End-Users

6.6. Global Tardive Dyskinesia Treatment Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Antipsychotic Medications

Benzodiazepines

Dopamine-Depleting Agents

Anticholinergic Agents

6.7. Global Tardive Dyskinesia Treatment Market, Sub-Segmentation Of Botulinum Toxin Injections, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Facial Muscle Injections

Neck Muscle Injections

Limb Muscle Injections

Customized Injection Protocols

6.8. Global Tardive Dyskinesia Treatment Market, Sub-Segmentation Of Deep Brain Stimulation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Subthalamic Nucleus Stimulation

Globus Pallidus Interna Stimulation

Thalamic Stimulation

Multi-Target Stimulation

6.9. Global Tardive Dyskinesia Treatment Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Supportive Therapies

Cognitive Behavioral Therapy

Physical Rehabilitation

Emerging Experimental Treatments

7. Tardive Dyskinesia Treatment Market Regional And Country Analysis

7.1. Global Tardive Dyskinesia Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Tardive Dyskinesia Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tardive Dyskinesia Treatment Market

8.1. Asia-Pacific Tardive Dyskinesia Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tardive Dyskinesia Treatment Market

9.1. China Tardive Dyskinesia Treatment Market Overview

9.2. China Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tardive Dyskinesia Treatment Market

10.1. India Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tardive Dyskinesia Treatment Market

11.1. Japan Tardive Dyskinesia Treatment Market Overview

11.2. Japan Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tardive Dyskinesia Treatment Market

12.1. Australia Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tardive Dyskinesia Treatment Market

13.1. Indonesia Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tardive Dyskinesia Treatment Market

14.1. South Korea Tardive Dyskinesia Treatment Market Overview

14.2. South Korea Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tardive Dyskinesia Treatment Market

15.1. Western Europe Tardive Dyskinesia Treatment Market Overview

15.2. Western Europe Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tardive Dyskinesia Treatment Market

16.1. UK Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tardive Dyskinesia Treatment Market

17.1. Germany Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tardive Dyskinesia Treatment Market

18.1. France Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tardive Dyskinesia Treatment Market

19.1. Italy Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tardive Dyskinesia Treatment Market

20.1. Spain Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tardive Dyskinesia Treatment Market

21.1. Eastern Europe Tardive Dyskinesia Treatment Market Overview

21.2. Eastern Europe Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tardive Dyskinesia Treatment Market

22.1. Russia Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tardive Dyskinesia Treatment Market

23.1. North America Tardive Dyskinesia Treatment Market Overview

23.2. North America Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tardive Dyskinesia Treatment Market

24.1. USA Tardive Dyskinesia Treatment Market Overview

24.2. USA Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tardive Dyskinesia Treatment Market

25.1. Canada Tardive Dyskinesia Treatment Market Overview

25.2. Canada Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tardive Dyskinesia Treatment Market

26.1. South America Tardive Dyskinesia Treatment Market Overview

26.2. South America Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tardive Dyskinesia Treatment Market

27.1. Brazil Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tardive Dyskinesia Treatment Market

28.1. Middle East Tardive Dyskinesia Treatment Market Overview

28.2. Middle East Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tardive Dyskinesia Treatment Market

29.1. Africa Tardive Dyskinesia Treatment Market Overview

29.2. Africa Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tardive Dyskinesia Treatment Market Competitive Landscape And Company Profiles

30.1. Tardive Dyskinesia Treatment Market Competitive Landscape

30.2. Tardive Dyskinesia Treatment Market Company Profiles

30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Takeda Pharmaceutical Company Limited Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Teva Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Otsuka Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Jazz Pharmaceuticals plc Overview, Products and Services, Strategy and Financial Analysis

31. Tardive Dyskinesia Treatment Market Other Major And Innovative Companies

31.1. Kyowa Kirin Co Ltd.

31.2. H. Lundbeck A/S

31.3. Zydus Lifesciences Limited

31.4. Neurocrine Biosciences Inc.

31.5. Luye Pharma Group Ltd.

31.6. Acadia Pharmaceuticals Inc.

31.7. Upsher-Smith Laboratories LLC

31.8. SteriMax Inc

31.9. Adamas Pharmaceuticals Inc.

31.10. ChemWerth Inc

31.11. Sunovion Pharmaceuticals Inc.

31.12. Mitsubishi Tanabe Pharma Corporation

31.13. Synnat Pharma Pvt. Ltd

31.14. LGM Pharma LLC

31.15. SOM Biotech S.A.

32. Global Tardive Dyskinesia Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tardive Dyskinesia Treatment Market

34. Recent Developments In The Tardive Dyskinesia Treatment Market

35. Tardive Dyskinesia Treatment Market High Potential Countries, Segments and Strategies

35.1 Tardive Dyskinesia Treatment Market In 2029 - Countries Offering Most New Opportunities

35.2 Tardive Dyskinesia Treatment Market In 2029 - Segments Offering Most New Opportunities

35.3 Tardive Dyskinesia Treatment Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Tardive Dyskinesia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Tardive Dyskinesia Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Tardive Dyskinesia Treatment Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Tardive Dyskinesia Treatment Market, Sub-Segmentation Of Botulinum Toxin Injections, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Tardive Dyskinesia Treatment Market, Sub-Segmentation Of Deep Brain Stimulation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Tardive Dyskinesia Treatment Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Tardive Dyskinesia Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Tardive Dyskinesia Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: AbbVie Inc. Financial Performance

Table 81: Takeda Pharmaceutical Company Limited Financial Performance

Table 82: Teva Pharmaceutical Industries Limited Financial Performance

Table 83: Otsuka Pharmaceutical Co. Ltd. Financial Performance

Table 84: Jazz Pharmaceuticals plc Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Tardive Dyskinesia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Tardive Dyskinesia Treatment Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Tardive Dyskinesia Treatment Market, Sub-Segmentation Of Medications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Tardive Dyskinesia Treatment Market, Sub-Segmentation Of Botulinum Toxin Injections, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Tardive Dyskinesia Treatment Market, Sub-Segmentation Of Deep Brain Stimulation, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Tardive Dyskinesia Treatment Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Tardive Dyskinesia Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Tardive Dyskinesia Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Tardive Dyskinesia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Tardive Dyskinesia Treatment Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Tardive Dyskinesia Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: AbbVie Inc. Financial Performance

Figure 81: Takeda Pharmaceutical Company Limited Financial Performance

Figure 82: Teva Pharmaceutical Industries Limited Financial Performance

Figure 83: Otsuka Pharmaceutical Co. Ltd. Financial Performance

Figure 84: Jazz Pharmaceuticals plc Financial Performance

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Tax Management Software Global Market Report 2025 – By Component (Software, Professional Services), By Tax Type (Direct Taxes, Indirect Taxes), By Deployment Mode (On-Premises, Cloud), By Enterprise Size (Large Enterpri...

Tax Management Global Market Report 2025 – By Type (Software, Services), By Deployment Mode (Cloud, On-Premises), By Organization Size (Small And Medium Sized Enterprises (SMES), Large Enterprises), By Application (Corpo...

Pet Tech Global Market Report 2025 – By Type (Radio Frequency Identification (RFID), Global Positioning System (GPS), Sensors, Other Types), By Distribution Channel (Offline, Online), By Application (Identification And T...

Information Technology Global Market Report 2025 – By Type (IT Services, Computer Hardware, Telecom, Software Products), By Organization Size (Large Enterprise, Small and Medium Enterprise), By End User (Financial Servic...

Legal Technology Global Market Report 2025 – By Type (Case Management, Lead Management, Document Management, Billing And Accounting, Other Types), By Solution (E-Discovery, Legal Research, Legal Analytics, Document Manag...

Space Technology (SpaceTech) Global Market Report 2025 – By Type (Space Vehicles, Spacecraft, Space Stations, Orbital Launch Vehicles, Deep-Space Communications, In-Space Propulsion, Other Types), By Application ( Naviga...

Revenue Assurance Global Market Report 2025 – By Component (Software, Services, Planning And Consulting, Implementation And Customization, Support And Maintenance, Managed Services), By Deployment Mode (Cloud, On-Premise...

Frequently Asked Questions

What is the definition of the Tardive Dyskinesia Treatment market?

How will the Tardive Dyskinesia Treatment market drivers and restraints affect the market dynamics? What forces will shape the Tardive Dyskinesia Treatment industry going forward?

The market major growth driver - The Rise In Psychiatric Disorders Driving The Growth Of The Market Due To Increasing Mental Health Burden. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Tardive Dyskinesia Treatment market?

The tardive dyskinesia treatment market size has grown strongly in recent years. It will grow from $2.40 billion in 2024 to $2.61 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to increasing use of antipsychotic medications, growing awareness of drug-induced movement disorders, rising incidence of schizophrenia and bipolar disorders, increasing off-label use of antipsychotics, and growing geriatric population using psychotropic drugs. The tardive dyskinesia treatment market size is expected to see strong growth in the next few years. It will grow to $3.61 billion in 2029 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to growing demand for safer antipsychotic therapies, rising awareness through advocacy and education campaigns, growing focus on personalized mental health treatments, rising healthcare spending on neurological and psychiatric disorders, and a growing number of psychiatric patients under long-term therapy. Major trends in the forecast period include developing neuroprotective strategies, developing dual-action therapies, integration of real-world evidence (RWE) in drug evaluation, integration of digital biomarkers, and innovation in non-dopaminergic therapeutics. For further insights on this market, request a sample here

How is the Tardive Dyskinesia Treatment market segmented?

The tardive dyskinesia treatment market covered in this report is segmented
1) By Treatment Type: Medications, Botulinum Toxin Injections, Deep Brain Stimulation, Other Treatment Types
2) By Drug: Valbenazine, Amantadine, Tetrabenazine, Clonazepam, Other Drugs
3) By Route Of Administration: Oral Administration, Injection, Transdermal Patches
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels
5) By End-Users: Hospitals, Specialty Clinics, Other End-Users Subsegments:
1) By Medications: Antipsychotic Medications, Benzodiazepines, Dopamine-Depleting Agents, Anticholinergic Agents
2) By Botulinum Toxin Injections: Facial Muscle Injections, Neck Muscle Injections, Limb Muscle Injections, Customized Injection Protocols
3) By Deep Brain Stimulation: Subthalamic Nucleus Stimulation, Globus Pallidus Interna Stimulation, Thalamic Stimulation, Multi-Target Stimulation
4) By Other Treatment Types: Supportive Therapies, Cognitive Behavioral Therapy, Physical Rehabilitation, Emerging Experimental Treatments For further insights on this market, request a sample here

Which region has the largest share of the Tardive Dyskinesia Treatment market? What are the other regions covered in the report?

North America was the largest region in the tardive dyskinesia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tardive dyskinesia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Tardive Dyskinesia Treatment market?

What are the key trends in the Tardive Dyskinesia Treatment market?

Major trends in this market include Innovative Drug Formulations Aim To Improve Care For Patients With Swallowing Difficulties. For further insights on this market, request a sample here.